Ajmera -A sunday revisit
Updated
it might look a bit messy at the first glance, but i used multiple systems
1.potential bearish harmonic pattern in completion of the bullish CD upleg
2.The ichimoku system as explained
3.Wyckoff reaccumualtion as explained
4.Wilder 52 week moving average support
5.Volume surges at support formed by the preliminary supply[psy]
6.Stoch rsi as explained
Over all a short term bullishness[in the trading range] in a reaccumulation phase which is in the infancy as of now, transiting from phase A to phase B of wyckoff reacc schematics... Markup seems will be around H2 fy20 and volatile sideways[220-360] might continue through out cy2018..
Disclaimer... invested and accumulating
not an investing/trading recommendation
Fundamentally good cash flows are due to come from the 3 signature projects Aeon, Zeon and Treon in mumbai, delivery has just commenced from november, 2017...
1.potential bearish harmonic pattern in completion of the bullish CD upleg
2.The ichimoku system as explained
3.Wyckoff reaccumualtion as explained
4.Wilder 52 week moving average support
5.Volume surges at support formed by the preliminary supply[psy]
6.Stoch rsi as explained
Over all a short term bullishness[in the trading range] in a reaccumulation phase which is in the infancy as of now, transiting from phase A to phase B of wyckoff reacc schematics... Markup seems will be around H2 fy20 and volatile sideways[220-360] might continue through out cy2018..
Disclaimer... invested and accumulating
not an investing/trading recommendation
Fundamentally good cash flows are due to come from the 3 signature projects Aeon, Zeon and Treon in mumbai, delivery has just commenced from november, 2017...
Note
monthy chart with stoch CCI, impending bullish cross in the over sold zoneNote
error in the idea posted.. the kijun n tenkan are in a bearish position post a bearish cross.... and in flat configuration..conclusion neutral in the bigger picture
Note
would be a screaming buy at 190 and 8 pe ratio...
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.